Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Apatinib mesylate tablet
Sponsors: Guilin Medical University, China; Wuzhou Red Cross Hospital; Guangxi Naxishan Hospital; National Hospital of Guangxi Zhuang Autonomous Region
Recruiting - verified April 2017
http://ift.tt/2qfhx8U
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου